Torrent Pharma Credit Rating Reaffirmed by India Ratings; Financials Show Growth
India Ratings and Research has reaffirmed Torrent Pharmaceuticals' credit rating at IND AA with a stable outlook, also assigning an A1 rating to its commercial paper program. The company, a leading player in the Indian pharmaceutical market with a global presence, reported a 30.46% rise in net profit and a 14.66% increase in net sales for Q2 September 2025 compared to the previous year. Torrent Pharma's securities committee will meet to consider issuing secured non-convertible debentures.
First-hand measurement across 1 source
We measured how 1 outlet covered this story. Coverage leans balanced overall (Left 0%, Centre 100%, Right 0%). Overall sentiment is positive (65/100). Lens Score 32/100.
Outlets measured: businessstandard. See how each one headlined and framed the same story in the source comparison below.
AI Analysis
All 1 outlets scored close to centre on political lean. The real divergence here is in emphasis, not lean — compare the headlines below to see how each outlet chose to frame the same facts.
Sentiment was consistent across outlets (65–65/100), indicating broadly factual reporting rather than editorialising.
Who's involved
Institutions and figures named across source coverage.